Albert Einstein College of Medicine receives $11.2 million NIH grant to study genes associated with longevity

Albert Einstein College of MedicineAug 28 2009

Research could lead to interventions to slow aging

The National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University a five-year, $11.2 million grant to study the impact of damage to DNA on aging and disease. Research funded by this grant, and conducted by a consortium of scientists, could reveal the role of genome maintenance systems in delaying aging and will begin to explore novel interventions to maintain health in old age.

Led by Jan Vijg, Ph.D., chairman of genetics at Einstein, the research project will build on the consortium's previous, internationally recognized work involving mice that undergo accelerated aging. This research has shown that interfering with the cellular processes responsible for DNA repair leads to what appears to be premature aging in these animals. These results indicate that accumulating DNA errors may underpin the aging process.

The investigators in the consortium now plan to see if treatments based on these results can extend life spans of mice bred to have short lives. "We can try to use interventions that are based on alleviating DNA damage," Dr. Vijg says. "One approach, for example, could be the use of antioxidants, which neutralize free radicals, the chemicals that contribute to DNA damage."

Altogether, the research project involves four main areas of study:

• unraveling the mechanisms that lead from DNA damage to premature as well as normal aging
• testing the role of DNA maintenance and repair as a pro-longevity system in humans
• developing sets of blood-based biomarkers that indicate premature aging in mouse models, and validate these biomarkers in normally aging mice and in humans
• developing new, experimental interventions that neutralize symptoms of premature aging in the short-lived mice

The NIH program project grant has funded five groups of scientists who are working on interrelated parts of the project's four research areas. In addition to Dr. Vijg's group, another Einstein team is headed by Yousin Suh, Ph.D., associate professor of medicine, and of genetics.

Dr. Suh will take advantage of a unique Einstein resource: tissue samples from Ashkenazi Jewish centenarians - living to age 100 and beyond. Using this relatively homogeneous population, brought together by her Einstein collaborator, Nir Barzilai, M.D., Dr. Suh will look for gene variations that are associated with longevity. Her team will test these "longevity genes" by inserting them into otherwise ordinary human cells and then observing whether the inserted genes improve cellular function.